Coeptis Therapeutics, Inc. Research and Development Expense
Coeptis Therapeutics, Inc. reported Research and Development Expense of $20.89 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2022-11-08
- Coeptis Therapeutics, Inc. research and development expense for the quarter ending 2022-09-30 was $20.89K.
- Coeptis Therapeutics, Inc. research and development expense for the quarter ending 2022-03-31 was $0.00.
- Coeptis Therapeutics, Inc. research and development expense for the quarter ending 2021-12-31 was $0.00.
- Coeptis Therapeutics, Inc. research and development expense for the quarter ending 2021-09-30 was $0.00.
- Coeptis Therapeutics, Inc. research and development expense for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Coeptis Therapeutics, Inc. research and development expense for fiscal 2020 was $3.54K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2022-09-30 | $20.89K 10-Q · filed 2022-11-08 | $20.89K 10-Q · filed 2022-11-08 | ||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | $0.00 derived: sum of 2 quarters · filed 2022-05-12 | $0.00 derived: sum of 3 quarters · filed 2022-11-08 | $0.00 derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 derived: sum of 3 quarters · filed 2022-11-08 | $0.00 10-K · filed 2022-03-11 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | $0.00 derived: sum of 3 quarters · filed 2022-05-12 | $0.00 derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | $0.00 derived: sum of 2 quarters · filed 2022-05-12 | $0.00 derived: sum of 3 quarters · filed 2022-05-12 | $3.54K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $0.00 derived: sum of 2 quarters · filed 2022-03-11 | $3.54K derived: sum of 3 quarters · filed 2022-03-11 | $3.54K 10-K · filed 2022-03-11 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $3.54K derived: sum of 2 quarters · filed 2021-11-15 | $3.54K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $3.54K 10-Q · filed 2021-08-16 | $3.54K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $0.00 10-Q/A · filed 2021-05-18 |